CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
ClariFixdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03791489
NCT03791489N/ACompleted
CompareCT.gov

Feasibility Study of Multi-Treatment Posterior Nasal Nerve (PNN) Modulation for Treatment of Chronic Rhinitis

Arrinex, Inc.·interventional·Posted Jan 2, 2019·Updated Jul 24, 2020

In Brief

A clinical study evaluating ClariFix for Chronic Rhinitis. Completed, enrolled 30 participants across 3 sites.

Detailed Summary

Feasibility of treatment at multiple sites with the ClariFix cryoablation device for treatment of chronic rhinitis

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Rhinitis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJan 2, 2019
Enrollment StartDec 1, 2018
Primary CompletionJul 18, 2019
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 7.5 years ago

Interventions

ClariFixdevice

The ClariFix™ device (K162608) is an FDA 510(k) cleared Class II cryosurgical tool indicated for the destruction of unwanted tissue during surgical procedures, including in adults with chronic rhinitis.